APO Research
Talk to an analyst

APO RESEARCH · REPORT

Celecoxib

Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.

The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.

Selected research

Industry Growth & Trends

Global Celecoxib Industry Growth and Trends Forecast to 2032

30 December 202594 pages

Choose your research edition.

Industry ResearchCelecoxib Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Celecoxib Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Celecoxib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Celecoxib Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Celecoxib Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.

The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.

Data show that more than 400 million people worldwide are currently affected by joint diseases.

Read the full market overview

The prevalence of osteoarthritis is 17 percent among people aged 40, 62 percent among people over 60 and 80 percent among people over 75.

The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing.

At present, the burden of chronic diseases will increase by 40% due to the aging of the population.

As the population ages, anti-inflammatory and anti-rheumatic drugs will enter a phase of rapid growth.

Globally, whether prescription drugs or non-prescription drugs, Xibu is widely used in clinical practice.

At present, the best seller in the international market is Celixib. Celixib market will continue to grow steadily in the next few years.

At present, the global Celecoxib market is basically occupied by Pfizer, which has formed an oligopoly.

It accounted for 63.39% of the global market in 2019.

As of 2019, China relies entirely on Pfizer for celecoxib imports.

Since 2020, some domestic drug companies have been gradually approved by FDA and CFDA. The introduction of celecoxib generic drugs by local companies will break the monopoly of import.

Report Scope

This report provides a structured, data-driven view of the global Celecoxib market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Celecoxib market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Celecoxib market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Celecoxib.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Celecoxib market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Celecoxib Market by Company

Pfizer Inc

Teva

Mylan

Apotex

Lupin

Hengrui Medicine

Celecoxib Segment by Type

50mg

100mg

200mg

400mg

Celecoxib Segment by Application

Rheumatoid arthritis

osteoarthritis

Acute pain

Musculoskeletal pain

Other diseases

Celecoxib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Celecoxib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Celecoxib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Celecoxib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Celecoxib manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Celecoxib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 50mg Table 2. Major Company of 100mg Table 3. Major Company of 200mg Table 4. Major Company of 400mg Table 5. Global Celecoxib Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Celecoxib Sales by Type (2021-2026) & (K Units) Table 7. Global Celecoxib Sales Market Share in Volume by Type (2021-2026) Table 8. Global Celecoxib Sales by Type (2021-2026) & (US$ Million) Table 9. Global Celecoxib Sales Market Share in Value by Type (2021-2026) Table 10. Global Celecoxib Price by Type (2021-2026) & (US$/Unit) Table 11. Global Celecoxib Sales by Type (2027-2032) & (K Units) Table 12. Global Celecoxib Sales Market Share in Volume by Type (2027-2032) Table 13. Global Celecoxib Sales by Type (2027-2032) & (US$ Million) Table 14. Global Celecoxib Sales Market Share in Value by Type (2027-2032) Table 15. Global Celecoxib Price by Type (2027-2032) & (US$/Unit) Table 16. North America Celecoxib Sales by Type (2021-2026) & (K Units) Table 17. North America Celecoxib Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Celecoxib Sales by Type (2021-2026) & (K Units) Table 19. Europe Celecoxib Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Celecoxib Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Celecoxib Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Celecoxib Sales by Type (2021-2026) & (K Units) Table 23. Latin America Celecoxib Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Celecoxib Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Celecoxib Sales by Type (2021-2026) & (US$ Million) Table 26. Celecoxib Industry Trends Table 27. Celecoxib Industry Drivers Table 28. Celecoxib Industry Opportunities and Challenges Table 29. Celecoxib Industry Restraints Table 30. Global Celecoxib Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Celecoxib Revenue Market Share by Company (2021-2026) Table 32. Global Celecoxib Sales by Company (2021-2026) & (K Units) Table 33. Global Celecoxib Sales Share by Company (2021-2026) Table 34. Global Celecoxib Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Celecoxib Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Celecoxib Major Company Production Sites and Headquarters Table 37. Global Celecoxib Company, Product Type & Application Table 38. Global Celecoxib Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Celecoxib by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Celecoxib Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Celecoxib Sales by Region (2021-2026) & (K Units) Table 43. Global Celecoxib Sales Market Share in Volume by Region (2021-2026) Table 44. Global Celecoxib Sales by Region (2021-2026) & (US$ Million) Table 45. Global Celecoxib Sales Market Share in Value by Region (2021-2026) Table 46. Global Celecoxib Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Celecoxib Sales by Region (2027-2032) & (K Units) Table 48. Global Celecoxib Sales Market Share in Volume by Region (2027-2032) Table 49. Global Celecoxib Sales by Region (2027-2032) & (US$ Million) Table 50. Global Celecoxib Sales Market Share in Value by Region (2027-2032) Table 51. Global Celecoxib Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Celecoxib Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Celecoxib Sales by Application (2021-2026) & (K Units) Table 54. Global Celecoxib Sales Market Share in Volume by Application (2021-2026) Table 55. Global Celecoxib Sales by Application (2021-2026) & (US$ Million) Table 56. Global Celecoxib Sales Market Share in Value by Application (2021-2026) Table 57. Global Celecoxib Price by Application (2021-2026) & (US$/Unit) Table 58. Global Celecoxib Sales by Application (2027-2032) & (K Units) Table 59. Global Celecoxib Sales Market Share in Volume by Application (2027-2032) Table 60. Global Celecoxib Sales by Application (2027-2032) & (US$ Million) Table 61. Global Celecoxib Sales Market Share in Value by Application (2027-2032) Table 62. Global Celecoxib Price by Application (2027-2032) & (US$/Unit) Table 63. North America Celecoxib Sales by Application (2021-2026) & (K Units) Table 64. North America Celecoxib Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Celecoxib Sales by Application (2021-2026) & (K Units) Table 66. Europe Celecoxib Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Celecoxib Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Celecoxib Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Celecoxib Sales by Application (2021-2026) & (K Units) Table 70. Latin America Celecoxib Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Celecoxib Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Celecoxib Sales by Application (2021-2026) & (US$ Million) Table 73. Pfizer Inc Company Information Table 74. Pfizer Inc Business Overview Table 75. Pfizer Inc Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Pfizer Inc Celecoxib Product Portfolio Table 77. Pfizer Inc Recent Development Table 78. Teva Company Information Table 79. Teva Business Overview Table 80. Teva Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Teva Celecoxib Product Portfolio Table 82. Teva Recent Development Table 83. Mylan Company Information Table 84. Mylan Business Overview Table 85. Mylan Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Mylan Celecoxib Product Portfolio Table 87. Mylan Recent Development Table 88. Apotex Company Information Table 89. Apotex Business Overview Table 90. Apotex Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Apotex Celecoxib Product Portfolio Table 92. Apotex Recent Development Table 93. Lupin Company Information Table 94. Lupin Business Overview Table 95. Lupin Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Lupin Celecoxib Product Portfolio Table 97. Lupin Recent Development Table 98. Hengrui Medicine Company Information Table 99. Hengrui Medicine Business Overview Table 100. Hengrui Medicine Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Hengrui Medicine Celecoxib Product Portfolio Table 102. Hengrui Medicine Recent Development Table 103. North America Celecoxib Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 104. North America Celecoxib Sales by Country (2021-2026) & (K Units) Table 105. North America Celecoxib Sales Market Share by Country (2021-2026) Table 106. North America Celecoxib Sales Forecast by Country (2027-2032) & (K Units) Table 107. North America Celecoxib Sales Market Share Forecast by Country (2027-2032) Table 108. North America Celecoxib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Celecoxib Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Celecoxib Market Share by Country (2021-2026) Table 111. North America Celecoxib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Celecoxib Market Share Forecast by Country (2027-2032) Table 113. Europe Celecoxib Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 114. Europe Celecoxib Sales by Country (2021-2026) & (K Units) Table 115. Europe Celecoxib Sales Market Share by Country (2021-2026) Table 116. Europe Celecoxib Sales Forecast by Country (2027-2032) & (K Units) Table 117. Europe Celecoxib Sales Market Share Forecast by Country (2027-2032) Table 118. Europe Celecoxib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Celecoxib Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Celecoxib Market Share by Country (2021-2026) Table 121. Europe Celecoxib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Celecoxib Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Celecoxib Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Celecoxib Sales by Country (2021-2026) & (K Units) Table 125. Asia-Pacific Celecoxib Sales Market Share by Country (2021-2026) Table 126. Asia-Pacific Celecoxib Sales Forecast by Country (2027-2032) & (K Units) Table 127. Asia-Pacific Celecoxib Sales Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Celecoxib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Celecoxib Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Celecoxib Market Share by Country (2021-2026) Table 131. Asia-Pacific Celecoxib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Celecoxib Market Share Forecast by Country (2027-2032) Table 133. Latin America Celecoxib Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. Latin America Celecoxib Sales by Country (2021-2026) & (K Units) Table 135. Latin America Celecoxib Sales Market Share by Country (2021-2026) Table 136. Latin America Celecoxib Sales Forecast by Country (2027-2032) & (K Units) Table 137. Latin America Celecoxib Sales Market Share Forecast by Country (2027-2032) Table 138. Latin America Celecoxib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Celecoxib Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Celecoxib Market Share by Country (2021-2026) Table 141. Latin America Celecoxib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Celecoxib Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Celecoxib Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Celecoxib Sales by Country (2021-2026) & (K Units) Table 145. Middle East and Africa Celecoxib Sales Market Share by Country (2021-2026) Table 146. Middle East and Africa Celecoxib Sales Forecast by Country (2027-2032) & (K Units) Table 147. Middle East and Africa Celecoxib Sales Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Celecoxib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Celecoxib Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East and Africa Celecoxib Market Share by Country (2021-2026) Table 151. Middle East and Africa Celecoxib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Celecoxib Market Share Forecast by Country (2027-2032) Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Celecoxib Distributors List Table 156. Celecoxib Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Celecoxib Image Figure 2. Global Celecoxib Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Celecoxib Market Size (2021-2032) & (US$ Million) Figure 4. Global Celecoxib Sales (2021-2032) & (K Units) Figure 5. 50mg Image Figure 6. Global 50mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 100mg Image Figure 8. Global 100mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. 200mg Image Figure 10. Global 200mg Sales YoY Growth (2021-2032) & (K Units) Figure 11. 400mg Image Figure 12. Global 400mg Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Celecoxib Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Celecoxib Market Share by Type 2025 VS 2032 Figure 15. North America Celecoxib Sales Market Share in Volume by Type in 2025 Figure 16. North America Celecoxib Sales Market Share in Value by Type in 2025 Figure 17. Europe Celecoxib Sales Market Share in Volume by Type in 2025 Figure 18. Europe Celecoxib Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Celecoxib Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Celecoxib Sales Market Share in Value by Type in 2025 Figure 21. Latin America Celecoxib Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Celecoxib Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Celecoxib Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Celecoxib Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Celecoxib Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Rheumatoid arthritis Image Figure 28. Global Rheumatoid arthritis Sales YoY Growth (2021-2032) & (K Units) Figure 29. osteoarthritis Image Figure 30. Global osteoarthritis Sales YoY Growth (2021-2032) & (K Units) Figure 31. Acute pain Image Figure 32. Global Acute pain Sales YoY Growth (2021-2032) & (K Units) Figure 33. Musculoskeletal pain Image Figure 34. Global Musculoskeletal pain Sales YoY Growth (2021-2032) & (K Units) Figure 35. Other diseases Image Figure 36. Global Other diseases Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Celecoxib Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Celecoxib Market Share by Application 2025 VS 2032 Figure 39. North America Celecoxib Sales Market Share in Volume by Application in 2025 Figure 40. North America Celecoxib Sales Market Share in Value by Application in 2025 Figure 41. Europe Celecoxib Sales Market Share in Volume by Application in 2025 Figure 42. Europe Celecoxib Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Celecoxib Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Celecoxib Sales Market Share in Value by Application in 2025 Figure 45. Latin America Celecoxib Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Celecoxib Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Celecoxib Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Celecoxib Sales Market Share in Value by Application in 2025 Figure 49. North America Celecoxib Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Celecoxib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Celecoxib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Celecoxib Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Celecoxib Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Celecoxib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Celecoxib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Celecoxib Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Celecoxib Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Celecoxib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Celecoxib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Celecoxib Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Celecoxib Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Celecoxib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Celecoxib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Celecoxib Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Celecoxib Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Celecoxib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Celecoxib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Celecoxib Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Celecoxib Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Celecoxib Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg
  • 100mg
  • 200mg
  • 400mg
Applications
  • Rheumatoid arthritis
  • osteoarthritis
  • Acute pain
  • Musculoskeletal pain
  • Other diseases
Companies covered
  • Pfizer Inc
  • Teva
  • Mylan
  • Apotex
  • Lupin
  • Hengrui Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Celecoxib Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Celecoxib Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Celecoxib Market by Type
  6. 1.3.1 50mg
  7. 1.3.2 100mg
  8. 1.3.3 200mg
  9. 1.3.4 400mg
  10. 1.4 Global Celecoxib Market Size by Type
  11. 1.4.1 Global Celecoxib Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Celecoxib Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Celecoxib Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Celecoxib Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Celecoxib Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Celecoxib Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Celecoxib Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Celecoxib Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Celecoxib Industry Trends
  2. 2.2 Celecoxib Industry Drivers
  3. 2.3 Celecoxib Industry Opportunities and Challenges
  4. 2.4 Celecoxib Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Celecoxib Revenue (2021-2026)
  2. 3.2 Global Top Players by Celecoxib Sales (2021-2026)
  3. 3.3 Global Top Players by Celecoxib Price (2021-2026)
  4. 3.4 Global Celecoxib Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Celecoxib Major Company Production Sites & Headquarters
  6. 3.6 Global Celecoxib Company, Product Type & Application
  7. 3.7 Global Celecoxib Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Celecoxib Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Celecoxib Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Celecoxib Tier 1, Tier 2, and Tier 3
4 Celecoxib Regional Status and Outlook
  1. 4.1 Global Celecoxib Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Celecoxib Historic Market Size by Region
  3. 4.2.1 Global Celecoxib Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Celecoxib Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Celecoxib Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Celecoxib Forecasted Market Size by Region
  7. 4.3.1 Global Celecoxib Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Celecoxib Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Celecoxib Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Celecoxib by Application
  1. 5.1 Celecoxib Market by Application
  2. 5.1.1 Rheumatoid arthritis
  3. 5.1.2 osteoarthritis
  4. 5.1.3 Acute pain
  5. 5.1.4 Musculoskeletal pain
  6. 5.1.5 Other diseases
  7. 5.2 Global Celecoxib Market Size by Application
  8. 5.2.1 Global Celecoxib Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Celecoxib Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Celecoxib Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Celecoxib Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Celecoxib Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Celecoxib Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Celecoxib Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Celecoxib Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Pfizer Inc
  2. 6.1.1 Pfizer Inc Company Information
  3. 6.1.2 Pfizer Inc Business Overview
  4. 6.1.3 Pfizer Inc Celecoxib Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Inc Celecoxib Product Portfolio
  6. 6.1.5 Pfizer Inc Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Celecoxib Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Celecoxib Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Celecoxib Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Celecoxib Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Apotex
  20. 6.4.1 Apotex Company Information
  21. 6.4.2 Apotex Business Overview
  22. 6.4.3 Apotex Celecoxib Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Apotex Celecoxib Product Portfolio
  24. 6.4.5 Apotex Recent Developments
  25. 6.5 Lupin
  26. 6.5.1 Lupin Company Information
  27. 6.5.2 Lupin Business Overview
  28. 6.5.3 Lupin Celecoxib Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lupin Celecoxib Product Portfolio
  30. 6.5.5 Lupin Recent Developments
  31. 6.6 Hengrui Medicine
  32. 6.6.1 Hengrui Medicine Company Information
  33. 6.6.2 Hengrui Medicine Business Overview
  34. 6.6.3 Hengrui Medicine Celecoxib Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hengrui Medicine Celecoxib Product Portfolio
  36. 6.6.5 Hengrui Medicine Recent Developments
7 North America by Country
  1. 7.1 North America Celecoxib Sales by Country
  2. 7.1.1 North America Celecoxib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Celecoxib Sales by Country (2021-2026)
  4. 7.1.3 North America Celecoxib Sales Forecast by Country (2027-2032)
  5. 7.2 North America Celecoxib Market Size by Country
  6. 7.2.1 North America Celecoxib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Celecoxib Market Size by Country (2021-2026)
  8. 7.2.3 North America Celecoxib Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Celecoxib Sales by Country
  2. 8.1.1 Europe Celecoxib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Celecoxib Sales by Country (2021-2026)
  4. 8.1.3 Europe Celecoxib Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Celecoxib Market Size by Country
  6. 8.2.1 Europe Celecoxib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Celecoxib Market Size by Country (2021-2026)
  8. 8.2.3 Europe Celecoxib Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Celecoxib Sales by Country
  2. 9.1.1 Asia-Pacific Celecoxib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Celecoxib Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Celecoxib Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Celecoxib Market Size by Country
  6. 9.2.1 Asia-Pacific Celecoxib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Celecoxib Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Celecoxib Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Celecoxib Sales by Country
  2. 10.1.1 South America Celecoxib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Celecoxib Sales by Country (2021-2026)
  4. 10.1.3 South America Celecoxib Sales Forecast by Country (2027-2032)
  5. 10.2 South America Celecoxib Market Size by Country
  6. 10.2.1 South America Celecoxib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Celecoxib Market Size by Country (2021-2026)
  8. 10.2.3 South America Celecoxib Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Celecoxib Sales by Country
  2. 11.1.1 Middle East and Africa Celecoxib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Celecoxib Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Celecoxib Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Celecoxib Market Size by Country
  6. 11.2.1 Middle East and Africa Celecoxib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Celecoxib Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Celecoxib Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Celecoxib Value Chain Analysis
  2. 12.1.1 Celecoxib Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Celecoxib Production Mode & Process
  7. 12.2 Celecoxib Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Celecoxib Distributors
  10. 12.2.3 Celecoxib Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst